U.S. Thrombectomy Devices Market by Technology (Mechanical Thrombectomy Devices, Aspiration Thrombectomy Devices, and Rheolytic Thrombectomy Devices), Type (Automated Thrombectomy Devices and Manual Thrombectomy Devices), Disease (Neurovascular Thrombectomy Devices, Peripheral Thrombectomy Devices, and Coronary Thrombectomy Devices), and Utility (Reusable Thrombectomy Devices and Disposable Thrombectomy Devices): Opportunity Analysis and Industry Forecast, 2018 - 2025
- LI_195195
- Pages: 119
- February 2019
- Total Views:1365
- Region : North America
- Allied Market Research
- Market Research Report
Details
According to a new report published by Allied Market Research, titled,"U.S. Thrombectomy Devices Market by Technology, Type. Disease and Utility: Opportunity Analysis and Industry Forecast, 2018-2025,"the U.S. thrombectomy devices market was valued at USD 501.9 million in 2017, and is projected to reach USD 750.4 million by 2025, growing at a CAGR of 5.1 % from 2018 to 2025. The mechanical thrombectomy devices used for peripheral and coronary disorders garner major shares of the market, and are expected to maintain this trend during the forecast period.
High prevalence of AMI, PAD, DVT, and PE, owing to sedentary and unhealthy lifestyle majorly drives the growth of the U.S. thrombectomy devices market. In addition, need for sophisticated healthcare infrastructure and increase in demand for minimally invasive treatments fuel the growth of the market. Moreover, rise in geriatric population, which increases incidence of cardiovascular diseases, and growth in competition among key players, which results in technological advancements and innovations significantly contribute toward the growth of the market. However, dearth of trained professionals, lack of awareness, and complicated use of thrombectomy devices restrain the market growth.
By technology, the thrombectomy devices market is categorized into mechanical, aspiration, and rheolytic thrombectomy devices. The mechanical thrombectomy devices segment is anticipated to dominate the market during the forecast period, due to increase in incidence of acute ischemic strokes, peripheral artery diseases, periphery embolism, and deep vein thrombosis, which prevail in blood vessels.
The use of thrombectomy devices for the treatment of neural disorders spearheaded the market in 2017, and trend is expected to continue throughout the forecast period. The manual thrombectomy devices segment was the highest revenue generator in 2017, due to ease of operating a manual thrombectomy device.
The disposable thrombectomy devices segment generated the highest revenue in 2017, and is expected to continue this trend throughout the analysis period, due to the fact that disposable devices reduce the chances of contamination and severity of in-hospitalization diseases. However, the reusable thrombectomy devices segment is anticipated to witness considerable growth in the near future, registering a CAGR of 6.9%, owing to advancements in the technology.
The U.S. thrombectomy devices market is a relatively consolidated market with the presence of several large players and other mid-sized manufacturers, which have started developing different thrombectomy devices and still have their products in the pipeline. Stryker Corporation, Medtronic Plc., Penumbra, Inc., and Boston Scientific Corporation garnered the top most position in 2017, owing to increase in sales and availability of products, namely, Trevo (Stryker), Solitaire Revascularization Device (Medtronic Plc.), and others majorly the country.
The key players profiled in this report include Boston Scientific Corporation, Medtronic Plc, Teleflex Incorporated, Penumbra Inc., Koninklijke Philips N.V., AngioDynamics, Inc., Terumo Corporation, Johnson and Johnson, Stryker Corporation, and Capture Vascular, Inc. The other players considered in the value chain analysis (but not in the report) include, Argon Medical Devices, Inc., Inari Medical, Inc., and others.
Key Findings of theU.S. Thrombectomy Devices Market:
In 2017, the mechanical thrombectomy devices segment generated the highest revenue, and is anticipated to dominate the market throughout the forecast period.
The peripheral thrombectomy devices segment is anticipated to grow at the highest rate from 2018 to 2025.
The disposable thrombectomy devices segment is anticipated to generate the highest revenue in 2025.
The automated thrombectomy devices is anticipated to register a CAGR of 6.9% from 2018 to 2025.
Table Of Content
Scope
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top winning strategies
3.2.2. Top investment pockets
3.3. Top player positioning, 2017
3.4. Porters five forces analysis
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. High prevalence of PDA, AMI, DVT, and PE
3.5.1.2. Surge in demand for minimally invasive procedures
3.5.1.3. Technological advancements & innovations
3.5.2. Restraints
3.5.2.1. High cost and complications associated with the use of thrombectomy devices
3.5.2.2. Dearth of trained professionals & lack of awareness
3.5.3. Opportunities
3.5.3.1. Introduction of lasers and UV radiation as well as 3D imaging generation in thrombectomy devices
3.5.3.2. Combination of decompressive surgery and thrombectomy
CHAPTER 4: U.S. THROMBECTOMY DEVICES MARKET, BY TECHNOLOGY
4.1. Overview
4.1.1. Market size and forecast
4.2. Mechanical thrombectomy devices
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.3. Aspiration thrombectomy devices
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.4. Rheolytic thrombectomy devices
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast
CHAPTER 5: U.S. THROMBECTOMY DEVICES MARKET, BY TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Automated thrombectomy devices
5.2.1. Market size and forecast
5.3. Manual thrombectomy devices
5.3.1. Market size and forecast
CHAPTER 6: U.S. THROMBECTOMY DEVICES MARKET, BY DISEASE
6.1. Overview
6.1.1. Market size and forecast
6.2. Neurovascular thrombectomy devices
6.2.1. Market size and forecast
6.3. Peripheral thrombectomy devices
6.3.1. Market size and forecast
6.4. Coronary thrombectomy devices
6.4.1. Market size and forecast
CHAPTER 7: U.S. THROMBECTOMY DEVICES MARKET, BY UTILITY
7.1. Overview
7.1.1. Market size and forecast
7.2. Reusable thrombectomy devices
7.2.1. Market size and forecast
7.3. Disposable thrombectomy devices
7.3.1. Market size and forecast
CHAPTER 8: COMPANY PROFILES
8.1. BOSTON SCIENTIFIC CORPORATION
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product Portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. JOHNSON & JOHNSON
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product Portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments
8.3. MEDTRONIC PLC
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments
8.4. Stryker Corporation
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic move and development
8.5. Teleflex Incorporated
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic move and development
8.6. TERUMO MEDICAL CORPORATION
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic move and development
8.7. KONINKLIJKE PHILIPS N.V.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Business performance
8.7.5. Product portfolio
8.7.6. Key strategic moves and developments
8.8. Angiodynamics Inc.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product Portfolio
8.8.5. Business performance
8.9. Penumbra, Inc.
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product Portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments
8.10. Capture Vascular, Inc.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
List Of Figure
LIST OF FIGURES
FIGURE 01. U.S. THROMBECTOMY DEVICE MARKET SEGMENTATION
FIGURE 02. TOP WINNING STRATEGIES, 20152018
FIGURE 03. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, 20152018
FIGURE 04. DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
FIGURE 05. TOP INVESTMENT POCKETS
FIGURE 06. TOP PLAYER POSITIONING, 2017
FIGURE 07. MODERATE BARGAINING POWER OF BUYERS
FIGURE 08. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 09. MODERATE THREAT OF NEW ENTRANTS
FIGURE 10. MODERATE THREAT OF SUBSTITUTION
FIGURE 11. HIGH COMPETITIVE RIVALRY
FIGURE 12. MARKET DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 13. U.S. THROMBECTOMY DEVICES MARKET FOR MECHANICAL THROMBECTOMY DEVICES, 20172025 (USD MILLION)
FIGURE 14. U.S. THROMBECTOMY DEVICES MARKET FOR ASPIRATION THROMBECTOMY DEVICES, 20172025 (USD MILLION)
FIGURE 15. U.S. THROMBECTOMY DEVICES MARKET FOR ASPIRATION THROMBECTOMY DEVICES, 20172025 (USD MILLION)
FIGURE 16. U.S. THROMBECTOMY DEVICES MARKET FOR AUTOMATED DEVICES, 20172025 (USD MILLION)
FIGURE 17. U.S. THROMBECTOMY DEVICES MARKET FOR MANUAL THROMBECTOMY DEVICES, 20172025 (USD MILLION)
FIGURE 18. U.S. THROMBECTOMY DEVICES MARKET FOR NEUROVASCULAR THROMBECTOMY DEVICES, 20172025 (USD MILLION)
FIGURE 19. U.S. THROMBECTOMY DEVICES MARKET FOR PERIPHERAL THROMBECTOMY DEVICES, 20172025 (USD MILLION)
FIGURE 20. U.S. THROMBECTOMY DEVICES MARKET FOR CORONARY THROMBECTOMY DEVICES, 20172025 (USD MILLION)
FIGURE 21. U.S. THROMBECTOMY DEVICES MARKET FOR REUSABLE THROMBECTOMY DEVICES, 20172025 (USD MILLION)
FIGURE 22. U.S. THROMBECTOMY DEVICES MARKET FOR DISPOSABLE THROMBECTOMY DEVICES, 20172025 (USD MILLION)
FIGURE 23. BOSTON SCIENTIFIC: NET SALES, 20152017 (USD MILLION)
FIGURE 24. BOSTON SCIENTIFIC: NET SALES, BY SEGMENT, 2017 (%)
FIGURE 25. BOSTON SCIENTIFIC: NET SALES, BY REGION, 2017 (%)
FIGURE 26. J&J: NET SALES, 20152017 (USD MILLION)
FIGURE 27. J&J: REVENUE SHARE, BY SEGMENT, 2017 (%)
FIGURE 28. J&J: REVENUE SHARE, BY REGION, 2017 (%)
FIGURE 29. MEDTRONIC: NET SALES, 20152017 (USD MILLION)
FIGURE 30. MEDTRONIC: NET SALES, BY SEGMENT, 2017 (%)
FIGURE 31. MEDTRONIC: NET SALES, BY REGION, 2017 (%)
FIGURE 32. STRYKER: NET SALES, 20152017 (USD MILLION)
FIGURE 33. STRYKER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 34. STRYKER: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 35. TELEFLEX: NET SALES, 20152017 (USD MILLION)
FIGURE 36. TELEFLEX: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 37. TERUMO MEDICAL CORPORATION: NET SALES, 20152017 (USD MILLION)
FIGURE 38. TERUMO MEDICAL CORPORATION: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 39. TERUMO MEDICAL CORPORATION: REVENUE SHARE BY REGION, 2016 (%)
FIGURE 40. PHILIPS: NET SALES, 20152017 (USD MILLION)
FIGURE 41. PHILIPS: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 42. PHILIPS: REVENUE SHARE BY REGION, 2017(%)
FIGURE 43. ANGIODYNAMICS INC: REVENUE, 20162018 (USD MILLION)
FIGURE 44. ANGIODYNAMICS INC.: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 45. ANGIODYNAMICS INC.: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 46. PENUMBRA, INC.: REVENUE, 20162018 (USD MILLION)
FIGURE 47. PENUMBRA, INC.: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 48. PENUMBRA, INC.: REVENUE SHARE BY REGION, 2017 (%)
List Of Table
LIST OF TABLES
TABLE 01. U.S. THROMBECTOMY DEVICES MARKET, BY TECHNOLOGY, 20172025 (USD MILLION)
TABLE 02. U.S. THROMBECTOMY DEVICES MARKET, BY TYPE, 20172025 (USD MILLION)
TABLE 03. U.S. THROMBECTOMY DEVICES MARKET, BY DISEASE, 20172025 (USD MILLION)
TABLE 04. U.S. THROMBECTOMY DEVICES MARKET, BY UTILITY, 20172025 (USD MILLION)
TABLE 05. BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 06. BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 07. BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 08. J&J: COMPANY SNAPSHOT
TABLE 09. J&J: OPERATING SEGMENTS
TABLE 10. J&J: PRODUCT PORTFOLIO
TABLE 11. MEDTRONIC: COMPANY SNAPSHOT
TABLE 12. MEDTRONIC: OPERATING SEGMENTS
TABLE 13. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 14. STRYKER: COMPANY SNAPSHOT
TABLE 15. STRYKER: OPERATING SEGMENTS
TABLE 16. STRYKER: PRODUCT PORTFOLIO
TABLE 17. TELEFLEX: COMPANY SNAPSHOT
TABLE 18. TELEFLEX: OPERATING SEGMENTS
TABLE 19. TELEFLEX: PRODUCT PORTFOLIO
TABLE 20. TERUMO MEDICAL CORPORATION: COMPANY SNAPSHOT
TABLE 21. TERUMO MEDICAL CORPORATION: OPERATING SEGMENTS
TABLE 22. TERUMO MEDICAL CORPORATION: PRODUCT PORTFOLIO
TABLE 23. PHILIPS: COMPANY SNAPSHOT
TABLE 24. PHILIPS: OPERATING SEGMENTS
TABLE 25. PHILIPS: PRODUCT PORTFOLIO
TABLE 26. ANGIODYNAMICS INC.: COMPANY SNAPSHOT
TABLE 27. ANGIODYNAMICS INC: OPERATING SEGMENTS
TABLE 28. ANGIODYNAMICS INC.: PRODUCT PORTFOLIO
TABLE 29. PENUMBRA, INC.: COMPANY SNAPSHOT
TABLE 30. PENUMBRA INC: OPERATING SEGMENTS
TABLE 31. PENUMBRA, INC.: PRODUCT PORTFOLIO
TABLE 32. CAPTURE VASCULAR, INC.: COMPANY SNAPSHOT
TABLE 33. CAPTURE VASCULAR, INC.: OPERATING BUSINESS SEGMENTS
TABLE 34. CAPTURE VASCULAR, INC: PRODUCT PORTFOLIO
Licence Rights
Single-User license:
This grants one non-exclusive, non-transferable machine-readable license for the report either electronically or online. The right to store, display, use, or stockpile the report is restricted to only ONE authorized computer. For obtaining a single user license, ONLY an individual ("you") for individual use is entitled for using the product or as mentioned in the License Terms. Any individual representing an organization is refrained from accessing the products/services of AMR or as stated in the License Terms; any breach of which shall lead to violation of applicable laws in the United States, India, or in the jurisdiction of purchase. The products and services offered are the intellectual property of AMR, and are protected by applicable copyright laws, international treaty provisions, and other applicable laws of the country in which these are being used. Albeit the abovementioned, you are NOT be permitted to:
transmit or permit any third party to use and/or gain access to the report;
resell, sub-license, rent, lease, transfer, or attempt to assign the rights of the report (in whole or in part) to any party NOT authorized by AMR;
modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use, or store the content from the report other than for internal business purposes; expressly permitted above; and
use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.
take photocopies, share with non-authorized users, and/or copy content from this publication to further distribute for commercial/noncommercial gains
share the information or content either electronically or in printed form with fellow-mates, public libraries, researchers, lecturers, college, university, foundation, government agency, corporate, non-profit organization or any other unauthorized users.
Five-User License:
This grants up to Five non-exclusive, non-transferable machine-readable licenses for using the report either electronically or online. The right to store, transfer, display, use, or stockpile the report is restricted to only FIVE authorized users. An individual representing an organization or an organization shall ONLY purchase the five-user license. The authorized users can print additional duplicate printed copies of the report for distribution to the employees of his/her company (Personnel). Albeit the abovementioned, you are NOT be permitted to:
transmit or permit by any means to any third party (i.e. non-personnel) or unauthorized users for use and/or gain access to the report;
resell, sub-license, rent, lease, transfer, or attempt to redistribute or assign rights of the report (in whole or in part) to any party NOT authorized by AMR;
modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use, or store the content from the report other than for internal business purposes; exclusively permitted above; and
use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.
take photocopies, share with non-authorized users, and/or copy content from this publication to further distribute for commercial or noncommercial gains.
share the information or content either electronically or as printed copies with fellow-mates, public libraries, researchers, lecturers, college, university, foundation, government agency, corporate, non-profit organization, or to more than 5 AUTHORIZED USERS.
Enterprise License:
This grants global, non-exclusive, non-transferable machine-readable licenses for using the report either electronically or online, within the organization and/or its subsidiaries. The authorized users shall have complete right to store, display, transfer, and/or use the report ONLY within the organization or its subsidiaries. Authorized users can take unlimited printed copies of the report for distribution among its employees. Albeit the abovementioned, you shall NOT be permitted to:
transmit or permit by any means to any third party (i.e. non-personnel) for use and/or gain access to the report;
resell, sub-license, rent, lease, transfer or attempt to assign the rights in the report (in whole or in part) to any party NOT authorized by AMR;
modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use or store the content from the report other than for internal business purposes; expressly permitted above; and
use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Company Profile
Company Profile Title
According to a new report published by Allied Market Research, titled,"U.S. Thrombectomy Devices Market by Technology, Type. Disease and Utility: Opportunity Analysis and Industry Forecast, 2018-2025,"the U.S. thrombectomy devices market was valued at USD 501.9 million in 2017, and is projected to reach USD 750.4 million by 2025, growing at a CAGR of 5.1 % from 2018 to 2025. The mechanical thrombectomy devices used for peripheral and coronary disorders garner major shares of the market, and are expected to maintain this trend during the forecast period.
High prevalence of AMI, PAD, DVT, and PE, owing to sedentary and unhealthy lifestyle majorly drives the growth of the U.S. thrombectomy devices market. In addition, need for sophisticated healthcare infrastructure and increase in demand for minimally invasive treatments fuel the growth of the market. Moreover, rise in geriatric population, which increases incidence of cardiovascular diseases, and growth in competition among key players, which results in technological advancements and innovations significantly contribute toward the growth of the market. However, dearth of trained professionals, lack of awareness, and complicated use of thrombectomy devices restrain the market growth.
By technology, the thrombectomy devices market is categorized into mechanical, aspiration, and rheolytic thrombectomy devices. The mechanical thrombectomy devices segment is anticipated to dominate the market during the forecast period, due to increase in incidence of acute ischemic strokes, peripheral artery diseases, periphery embolism, and deep vein thrombosis, which prevail in blood vessels.
The use of thrombectomy devices for the treatment of neural disorders spearheaded the market in 2017, and trend is expected to continue throughout the forecast period. The manual thrombectomy devices segment was the highest revenue generator in 2017, due to ease of operating a manual thrombectomy device.
The disposable thrombectomy devices segment generated the highest revenue in 2017, and is expected to continue this trend throughout the analysis period, due to the fact that disposable devices reduce the chances of contamination and severity of in-hospitalization diseases. However, the reusable thrombectomy devices segment is anticipated to witness considerable growth in the near future, registering a CAGR of 6.9%, owing to advancements in the technology.
The U.S. thrombectomy devices market is a relatively consolidated market with the presence of several large players and other mid-sized manufacturers, which have started developing different thrombectomy devices and still have their products in the pipeline. Stryker Corporation, Medtronic Plc., Penumbra, Inc., and Boston Scientific Corporation garnered the top most position in 2017, owing to increase in sales and availability of products, namely, Trevo (Stryker), Solitaire Revascularization Device (Medtronic Plc.), and others majorly the country.
The key players profiled in this report include Boston Scientific Corporation, Medtronic Plc, Teleflex Incorporated, Penumbra Inc., Koninklijke Philips N.V., AngioDynamics, Inc., Terumo Corporation, Johnson and Johnson, Stryker Corporation, and Capture Vascular, Inc. The other players considered in the value chain analysis (but not in the report) include, Argon Medical Devices, Inc., Inari Medical, Inc., and others.
Key Findings of theU.S. Thrombectomy Devices Market:
In 2017, the mechanical thrombectomy devices segment generated the highest revenue, and is anticipated to dominate the market throughout the forecast period.
The peripheral thrombectomy devices segment is anticipated to grow at the highest rate from 2018 to 2025.
The disposable thrombectomy devices segment is anticipated to generate the highest revenue in 2025.
The automated thrombectomy devices is anticipated to register a CAGR of 6.9% from 2018 to 2025.
Scope
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top winning strategies
3.2.2. Top investment pockets
3.3. Top player positioning, 2017
3.4. Porters five forces analysis
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. High prevalence of PDA, AMI, DVT, and PE
3.5.1.2. Surge in demand for minimally invasive procedures
3.5.1.3. Technological advancements & innovations
3.5.2. Restraints
3.5.2.1. High cost and complications associated with the use of thrombectomy devices
3.5.2.2. Dearth of trained professionals & lack of awareness
3.5.3. Opportunities
3.5.3.1. Introduction of lasers and UV radiation as well as 3D imaging generation in thrombectomy devices
3.5.3.2. Combination of decompressive surgery and thrombectomy
CHAPTER 4: U.S. THROMBECTOMY DEVICES MARKET, BY TECHNOLOGY
4.1. Overview
4.1.1. Market size and forecast
4.2. Mechanical thrombectomy devices
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.3. Aspiration thrombectomy devices
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.4. Rheolytic thrombectomy devices
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast
CHAPTER 5: U.S. THROMBECTOMY DEVICES MARKET, BY TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Automated thrombectomy devices
5.2.1. Market size and forecast
5.3. Manual thrombectomy devices
5.3.1. Market size and forecast
CHAPTER 6: U.S. THROMBECTOMY DEVICES MARKET, BY DISEASE
6.1. Overview
6.1.1. Market size and forecast
6.2. Neurovascular thrombectomy devices
6.2.1. Market size and forecast
6.3. Peripheral thrombectomy devices
6.3.1. Market size and forecast
6.4. Coronary thrombectomy devices
6.4.1. Market size and forecast
CHAPTER 7: U.S. THROMBECTOMY DEVICES MARKET, BY UTILITY
7.1. Overview
7.1.1. Market size and forecast
7.2. Reusable thrombectomy devices
7.2.1. Market size and forecast
7.3. Disposable thrombectomy devices
7.3.1. Market size and forecast
CHAPTER 8: COMPANY PROFILES
8.1. BOSTON SCIENTIFIC CORPORATION
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product Portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. JOHNSON & JOHNSON
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product Portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments
8.3. MEDTRONIC PLC
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments
8.4. Stryker Corporation
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic move and development
8.5. Teleflex Incorporated
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic move and development
8.6. TERUMO MEDICAL CORPORATION
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic move and development
8.7. KONINKLIJKE PHILIPS N.V.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Business performance
8.7.5. Product portfolio
8.7.6. Key strategic moves and developments
8.8. Angiodynamics Inc.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product Portfolio
8.8.5. Business performance
8.9. Penumbra, Inc.
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product Portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments
8.10. Capture Vascular, Inc.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
List Of Figure
LIST OF FIGURES
FIGURE 01. U.S. THROMBECTOMY DEVICE MARKET SEGMENTATION
FIGURE 02. TOP WINNING STRATEGIES, 20152018
FIGURE 03. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, 20152018
FIGURE 04. DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
FIGURE 05. TOP INVESTMENT POCKETS
FIGURE 06. TOP PLAYER POSITIONING, 2017
FIGURE 07. MODERATE BARGAINING POWER OF BUYERS
FIGURE 08. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 09. MODERATE THREAT OF NEW ENTRANTS
FIGURE 10. MODERATE THREAT OF SUBSTITUTION
FIGURE 11. HIGH COMPETITIVE RIVALRY
FIGURE 12. MARKET DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 13. U.S. THROMBECTOMY DEVICES MARKET FOR MECHANICAL THROMBECTOMY DEVICES, 20172025 (USD MILLION)
FIGURE 14. U.S. THROMBECTOMY DEVICES MARKET FOR ASPIRATION THROMBECTOMY DEVICES, 20172025 (USD MILLION)
FIGURE 15. U.S. THROMBECTOMY DEVICES MARKET FOR ASPIRATION THROMBECTOMY DEVICES, 20172025 (USD MILLION)
FIGURE 16. U.S. THROMBECTOMY DEVICES MARKET FOR AUTOMATED DEVICES, 20172025 (USD MILLION)
FIGURE 17. U.S. THROMBECTOMY DEVICES MARKET FOR MANUAL THROMBECTOMY DEVICES, 20172025 (USD MILLION)
FIGURE 18. U.S. THROMBECTOMY DEVICES MARKET FOR NEUROVASCULAR THROMBECTOMY DEVICES, 20172025 (USD MILLION)
FIGURE 19. U.S. THROMBECTOMY DEVICES MARKET FOR PERIPHERAL THROMBECTOMY DEVICES, 20172025 (USD MILLION)
FIGURE 20. U.S. THROMBECTOMY DEVICES MARKET FOR CORONARY THROMBECTOMY DEVICES, 20172025 (USD MILLION)
FIGURE 21. U.S. THROMBECTOMY DEVICES MARKET FOR REUSABLE THROMBECTOMY DEVICES, 20172025 (USD MILLION)
FIGURE 22. U.S. THROMBECTOMY DEVICES MARKET FOR DISPOSABLE THROMBECTOMY DEVICES, 20172025 (USD MILLION)
FIGURE 23. BOSTON SCIENTIFIC: NET SALES, 20152017 (USD MILLION)
FIGURE 24. BOSTON SCIENTIFIC: NET SALES, BY SEGMENT, 2017 (%)
FIGURE 25. BOSTON SCIENTIFIC: NET SALES, BY REGION, 2017 (%)
FIGURE 26. J&J: NET SALES, 20152017 (USD MILLION)
FIGURE 27. J&J: REVENUE SHARE, BY SEGMENT, 2017 (%)
FIGURE 28. J&J: REVENUE SHARE, BY REGION, 2017 (%)
FIGURE 29. MEDTRONIC: NET SALES, 20152017 (USD MILLION)
FIGURE 30. MEDTRONIC: NET SALES, BY SEGMENT, 2017 (%)
FIGURE 31. MEDTRONIC: NET SALES, BY REGION, 2017 (%)
FIGURE 32. STRYKER: NET SALES, 20152017 (USD MILLION)
FIGURE 33. STRYKER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 34. STRYKER: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 35. TELEFLEX: NET SALES, 20152017 (USD MILLION)
FIGURE 36. TELEFLEX: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 37. TERUMO MEDICAL CORPORATION: NET SALES, 20152017 (USD MILLION)
FIGURE 38. TERUMO MEDICAL CORPORATION: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 39. TERUMO MEDICAL CORPORATION: REVENUE SHARE BY REGION, 2016 (%)
FIGURE 40. PHILIPS: NET SALES, 20152017 (USD MILLION)
FIGURE 41. PHILIPS: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 42. PHILIPS: REVENUE SHARE BY REGION, 2017(%)
FIGURE 43. ANGIODYNAMICS INC: REVENUE, 20162018 (USD MILLION)
FIGURE 44. ANGIODYNAMICS INC.: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 45. ANGIODYNAMICS INC.: REVENUE SHARE BY REGION, 2017 (%)
FIGURE 46. PENUMBRA, INC.: REVENUE, 20162018 (USD MILLION)
FIGURE 47. PENUMBRA, INC.: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 48. PENUMBRA, INC.: REVENUE SHARE BY REGION, 2017 (%)
List Of Table
LIST OF TABLES
TABLE 01. U.S. THROMBECTOMY DEVICES MARKET, BY TECHNOLOGY, 20172025 (USD MILLION)
TABLE 02. U.S. THROMBECTOMY DEVICES MARKET, BY TYPE, 20172025 (USD MILLION)
TABLE 03. U.S. THROMBECTOMY DEVICES MARKET, BY DISEASE, 20172025 (USD MILLION)
TABLE 04. U.S. THROMBECTOMY DEVICES MARKET, BY UTILITY, 20172025 (USD MILLION)
TABLE 05. BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 06. BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 07. BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 08. J&J: COMPANY SNAPSHOT
TABLE 09. J&J: OPERATING SEGMENTS
TABLE 10. J&J: PRODUCT PORTFOLIO
TABLE 11. MEDTRONIC: COMPANY SNAPSHOT
TABLE 12. MEDTRONIC: OPERATING SEGMENTS
TABLE 13. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 14. STRYKER: COMPANY SNAPSHOT
TABLE 15. STRYKER: OPERATING SEGMENTS
TABLE 16. STRYKER: PRODUCT PORTFOLIO
TABLE 17. TELEFLEX: COMPANY SNAPSHOT
TABLE 18. TELEFLEX: OPERATING SEGMENTS
TABLE 19. TELEFLEX: PRODUCT PORTFOLIO
TABLE 20. TERUMO MEDICAL CORPORATION: COMPANY SNAPSHOT
TABLE 21. TERUMO MEDICAL CORPORATION: OPERATING SEGMENTS
TABLE 22. TERUMO MEDICAL CORPORATION: PRODUCT PORTFOLIO
TABLE 23. PHILIPS: COMPANY SNAPSHOT
TABLE 24. PHILIPS: OPERATING SEGMENTS
TABLE 25. PHILIPS: PRODUCT PORTFOLIO
TABLE 26. ANGIODYNAMICS INC.: COMPANY SNAPSHOT
TABLE 27. ANGIODYNAMICS INC: OPERATING SEGMENTS
TABLE 28. ANGIODYNAMICS INC.: PRODUCT PORTFOLIO
TABLE 29. PENUMBRA, INC.: COMPANY SNAPSHOT
TABLE 30. PENUMBRA INC: OPERATING SEGMENTS
TABLE 31. PENUMBRA, INC.: PRODUCT PORTFOLIO
TABLE 32. CAPTURE VASCULAR, INC.: COMPANY SNAPSHOT
TABLE 33. CAPTURE VASCULAR, INC.: OPERATING BUSINESS SEGMENTS
TABLE 34. CAPTURE VASCULAR, INC: PRODUCT PORTFOLIO
Single-User license:
This grants one non-exclusive, non-transferable machine-readable license for the report either electronically or online. The right to store, display, use, or stockpile the report is restricted to only ONE authorized computer. For obtaining a single user license, ONLY an individual ("you") for individual use is entitled for using the product or as mentioned in the License Terms. Any individual representing an organization is refrained from accessing the products/services of AMR or as stated in the License Terms; any breach of which shall lead to violation of applicable laws in the United States, India, or in the jurisdiction of purchase. The products and services offered are the intellectual property of AMR, and are protected by applicable copyright laws, international treaty provisions, and other applicable laws of the country in which these are being used. Albeit the abovementioned, you are NOT be permitted to:
transmit or permit any third party to use and/or gain access to the report;
resell, sub-license, rent, lease, transfer, or attempt to assign the rights of the report (in whole or in part) to any party NOT authorized by AMR;
modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use, or store the content from the report other than for internal business purposes; expressly permitted above; and
use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.
take photocopies, share with non-authorized users, and/or copy content from this publication to further distribute for commercial/noncommercial gains
share the information or content either electronically or in printed form with fellow-mates, public libraries, researchers, lecturers, college, university, foundation, government agency, corporate, non-profit organization or any other unauthorized users.
Five-User License:
This grants up to Five non-exclusive, non-transferable machine-readable licenses for using the report either electronically or online. The right to store, transfer, display, use, or stockpile the report is restricted to only FIVE authorized users. An individual representing an organization or an organization shall ONLY purchase the five-user license. The authorized users can print additional duplicate printed copies of the report for distribution to the employees of his/her company (Personnel). Albeit the abovementioned, you are NOT be permitted to:
transmit or permit by any means to any third party (i.e. non-personnel) or unauthorized users for use and/or gain access to the report;
resell, sub-license, rent, lease, transfer, or attempt to redistribute or assign rights of the report (in whole or in part) to any party NOT authorized by AMR;
modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use, or store the content from the report other than for internal business purposes; exclusively permitted above; and
use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.
take photocopies, share with non-authorized users, and/or copy content from this publication to further distribute for commercial or noncommercial gains.
share the information or content either electronically or as printed copies with fellow-mates, public libraries, researchers, lecturers, college, university, foundation, government agency, corporate, non-profit organization, or to more than 5 AUTHORIZED USERS.
Enterprise License:
This grants global, non-exclusive, non-transferable machine-readable licenses for using the report either electronically or online, within the organization and/or its subsidiaries. The authorized users shall have complete right to store, display, transfer, and/or use the report ONLY within the organization or its subsidiaries. Authorized users can take unlimited printed copies of the report for distribution among its employees. Albeit the abovementioned, you shall NOT be permitted to:
transmit or permit by any means to any third party (i.e. non-personnel) for use and/or gain access to the report;
resell, sub-license, rent, lease, transfer or attempt to assign the rights in the report (in whole or in part) to any party NOT authorized by AMR;
modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use or store the content from the report other than for internal business purposes; expressly permitted above; and
use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Ask A Question
Our Team Will Assist You in What You Are Looking For
or 
: +91 98100 26150
: ankurgupta1984
Related Reports
Page 179 | 
February 2020
Page 116 | January 2020
Page 235 | January 2020
Page 183 | September 2019
Page 244 | August 2019